Correction: BMS Exec Pleads Guilty Over Plavix Deal
The former vice president of Bristol-Myers Squibb Co. pled guilty to charges of lying to government regulators about a furtive and anti-competitive patent deal for the blockbuster blood-thinning drug Plavix....To view the full article, register now.
Already a subscriber? Click here to view full article